Clinical trial
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage…
NCT00002618 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002618 |
|---|---|
| Title | Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma |
| Official title | A Phase III Study of Large Cell Lymphomas in Children and Adolescents: Comparison of APO vs APO + IDMTX/HDARA-C and Continuous vs Bolus Infusion of Doxorubicin |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cytarabine, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, prednisone, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET electron therapy and 1 more |
| Enrollment | 242 |
| Start date | Dec 1, 1994 |
| Primary completion | Sep 1, 2000 |
| Completion | Sep 1, 2006 |
| First posted | Jul 29, 2004 |
| Last update posted | Jul 24, 2014 |
| Countries | Puerto Rico, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: